Lilly slightly lowers self-pay prices for single-dose vials of Zepboundnews2025-12-01T14:37:47+00:00December 1st, 2025|Endpoints News|
“Heavy AI” is taking over biopharma | Signal Pulse Reportnews2025-12-01T13:53:30+00:00December 1st, 2025|Endpoints News|
Introducing Endpoints Signal — intelligence for fresh biopharma insightsnews2025-12-01T13:53:11+00:00December 1st, 2025|Endpoints News|
Gene writing startup Tessera strikes $150M partnership with Regeneronnews2025-12-01T12:00:18+00:00December 1st, 2025|Endpoints News|
Protego gets $130M for AL amyloidosis drug from leaders behind Vyndaqelnews2025-12-01T11:00:24+00:00December 1st, 2025|Endpoints News|
Generate:Biomedicines to start Phase 3 studies for TSLP antibodynews2025-12-01T11:00:16+00:00December 1st, 2025|Endpoints News|
Novo’s MFN prices to supersede IRA prices for Ozempic, Wegovy, CMS saysnews2025-11-26T19:14:48+00:00November 26th, 2025|Endpoints News|
Lundbeck backs out of bidding war for sleep disorder biotech Avadelnews2025-11-26T18:11:34+00:00November 26th, 2025|Endpoints News|
Novo submits high-dose Wegovy for FDA approval using vouchernews2025-11-26T17:45:45+00:00November 26th, 2025|Endpoints News|
